David Miller, the co-founder and CEO of Biotech Stock Research, an independent stock research firm in Seattle, has filed paperwork to run for the Seattle City Council. Miller plans to continue operating his stock newsletter throughout the campaign which ends in November 2009, and plans to keep the company operating if he wins, he and partner Alan Leong said today in a letter to subscribers. Miller has been volunteering in recent years, and “believes the best way to make a difference” in his hometown is to join the council, he said in the note.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
